Skip to content
Frisco News

Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: ‘A new frontier'

Experimental mRNA cancer vaccine cuts risk of melanoma returning by 42%: ‘A new frontier'
Photo: NBC 5 Dallas-Fort Worth (KXAS) - Top Stories · view original

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. The vaccine was custom-brewed for each patient to match their tumor. Adding it to a standard...

Sources and story details